Umbilical Cord Mesenchymal Stem Cells: A Novel Approach to Intervention of Ovarian Ageing

Overview

Journal Regen Ther

Date 2024 Sep 9

PMID 39246700

Authors

Chuan Tian

Li Ye

Xilong Zhao

Xiangqing Zhu

Jun Xu

Xinghua Pan

Affiliations

Soon will be listed here.

Abstract

Ovarian aging leads to endocrine disorders and systemic degeneration of tissue and organ structure and function, seriously affecting women's physical and mental health. Safe and effective treatments for this condition are lacking. Umbilical cord mesenchymal stem cells (UCMSCs), which have multidirectional differentiation potential, show strong self-renewal, secrete bioactive factors and release exosomes, can undergo homing, colonization, integration and differentiation into supporting and functional cells in tissues and organs through direct manipulation and can also improve the tissue microenvironment through paracrine action, promoting cell division, proliferation and microangiogenesis, inhibiting inflammation and apoptosis, reducing oxidative stress, and mediating two-way immune regulation. These processes activate dormant cells, repaired damaged cells, replace necrotic cells, and regenerate fresh cells, restoring the structure and function of the ageing ovary. Furthermore, with the increasing development of UCMSC research and technology, the therapeutic use of UCMSCs is expected to become an effective means for the treatment of ovarian ageing caused by tissue cell ageing, degeneration, and necrosis.

References

Jiao W, Mi X, Yang Y, Liu R, Liu Q, Yan T . Mesenchymal stem cells combined with autocrosslinked hyaluronic acid improve mouse ovarian function by activating the PI3K-AKT pathway in a paracrine manner. Stem Cell Res Ther. 2022; 13(1):49. PMC: 8812195. DOI: 10.1186/s13287-022-02724-3. View

Wu Y, Zhang H, Wang S, Li L, Wang R, Jiang S . Human umbilical cord-derived stem cell sheets improve left ventricular function in rat models of ischemic heart failure. Eur J Pharmacol. 2022; 925:174994. DOI: 10.1016/j.ejphar.2022.174994. View

Li Z, Zhang M, Zheng J, Tian Y, Zhang H, Tan Y . Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Improve Ovarian Function and Proliferation of Premature Ovarian Insufficiency by Regulating the Hippo Signaling Pathway. Front Endocrinol (Lausanne). 2021; 12:711902. PMC: 8397419. DOI: 10.3389/fendo.2021.711902. View

Pan X, Li Q, Zhu X, Li Z, Cai X, Pang R . Mechanism and therapeutic effect of umbilical cord mesenchymal stem cells in inflammatory bowel disease. Sci Rep. 2019; 9(1):17646. PMC: 6881332. DOI: 10.1038/s41598-019-54194-y. View

Xu L, Yuan S, Chen W, Ma Y, Luo Y, Guo W . Transplantation and Tracking of the Human Umbilical Cord Mesenchymal Stem Cell Labeled with Superparamagnetic Iron Oxide in Deaf Pigs. Anat Rec (Hoboken). 2020; 303(3):494-505. DOI: 10.1002/ar.24346. View

Zhang X, Wang T, Wang Z, Huang K, Zhang Y, Wang G . Hypoxic ucMSC-secreted exosomal miR-125b promotes endothelial cell survival and migration during wound healing by targeting TP53INP1. Mol Ther Nucleic Acids. 2021; 26:347-359. PMC: 8416974. DOI: 10.1016/j.omtn.2021.07.014. View

Du J, Wang X, Li Y, Ren X, Zhou Y, Hu W . DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Cell Death Dis. 2021; 12(7):705. PMC: 8280115. DOI: 10.1038/s41419-021-03996-y. View

Alzhrani G, Alanazi S, Alsharif S, Albalawi A, Alsharif A, Abdel-Maksoud M . Exosomes: Isolation, characterization, and biomedical applications. Cell Biol Int. 2021; 45(9):1807-1831. DOI: 10.1002/cbin.11620. View

Zhao Y, Yang X, Li S, Zhang B, Li S, Wang X . sTNFRII-Fc modification protects human UC-MSCs against apoptosis/autophagy induced by TNF-α and enhances their efficacy in alleviating inflammatory arthritis. Stem Cell Res Ther. 2021; 12(1):535. PMC: 8502322. DOI: 10.1186/s13287-021-02602-4. View

10.

Ruan G, Yao X, Mo P, Wang K, Yang Z, Tian N . Establishment of a Systemic Inflammatory Response Syndrome Model and Evaluation of the Efficacy of Umbilical Cord Mesenchymal Stem Cell Transplantation. Cells Tissues Organs. 2021; 210(2):118-134. DOI: 10.1159/000514619. View

11.

Meng F, Xu R, Wang S, Xu Z, Zhang C, Li Y . Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. 2020; 5(1):172. PMC: 7450163. DOI: 10.1038/s41392-020-00286-5. View

12.

Liang Q, Li Q, Ren B, Yin Z . Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats. BMC Ophthalmol. 2022; 22(1):67. PMC: 8832832. DOI: 10.1186/s12886-021-02171-3. View

13.

Morrison S, Spradling A . Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 2008; 132(4):598-611. PMC: 4505728. DOI: 10.1016/j.cell.2008.01.038. View

14.

Pan X, Zhang X, Yao X, Tian N, Yang Z, Wang K . Effects and mechanisms of mUCMSCs on ovarian structure and function in naturally ageing C57 mice. J Ovarian Res. 2021; 14(1):133. PMC: 8515706. DOI: 10.1186/s13048-021-00854-5. View

15.

Xiang E, Han B, Zhang Q, Rao W, Wang Z, Chang C . Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020; 11(1):336. PMC: 7397631. DOI: 10.1186/s13287-020-01852-y. View

16.

Zhang K, Sun H, Cao H, Jia Y, Shu X, Cao H . The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis. Stem Cell Res Ther. 2021; 12(1):466. PMC: 8379867. DOI: 10.1186/s13287-021-02544-x. View

17.

Cui L, Bao H, Zhu W, Tang Y, Luo Q, Si Y . hUMSCs Transplantation Regulates AMPK/NR4A1 Signaling Axis to Inhibit Ovarian Fibrosis in POI Rats. Stem Cell Rev Rep. 2022; 19(5):1449-1465. DOI: 10.1007/s12015-022-10469-y. View

18.

Ma D, Wu Z, Zhao X, Zhu X, An Q, Wang Y . Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4 T cells in patients with primary Sjögren's syndrome. Inflammopharmacology. 2023; 31(4):1823-1838. PMC: 10352432. DOI: 10.1007/s10787-023-01189-x. View

19.

Sun Q, Hong L, Huang Z, Na N, Hua X, Peng Y . Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial. Trials. 2017; 18(1):545. PMC: 5689202. DOI: 10.1186/s13063-017-2291-y. View

20.

Li H, Jin Y, Zhao Y, Li W, He Z, Zhang Q . Targeted cell therapy for partial-thickness cartilage defects using membrane modified mesenchymal stem cells by transglutaminase 2. Biomaterials. 2021; 275:120994. DOI: 10.1016/j.biomaterials.2021.120994. View